Application of HIPEC simulations for optimizing treatment delivery strategies

Application of HIPEC simulations for optimizing treatment delivery strategies

AbstractIntroduction Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) aims to treat microscopic disease left after CytoReductive Surgery (CRS). Thermal enhancement depends on the temperatures achieved. Since the location of microscopic disease is unknown, a homogeneous treatment is required to comp...

Full description

Bibliographic Details
Main Authors:	Daan R. Löke, H. Petra Kok, Roxan F. C. P. A Helderman, Bella Bokan, Nicolaas A. P. Franken, Arlene L. Oei, Jurriaan B. Tuynman, Pieter J. Tanis, Johannes Crezee
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	International Journal of Hyperthermia
Subjects:	Hyperthermic intrapertioneal chemotherapy (HIPEC) computational fluid dynamics(CFD) computational modeling cancer biology drug dynamics treatment planning software
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2023.2218627

Similar Items

Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
by: Daan R. Löke, et al.
Published: (2023-02-01)

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
by: Daan R. Löke, et al.
Published: (2021-01-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
by: Roxan F. C. P. A. Helderman, et al.
Published: (2021-07-01)

The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
by: Roxan F.C.P.A. Helderman, et al.
Published: (2020-07-01)

Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
by: Roxan F. C. P. A. Helderman, et al.
Published: (2023-03-01)

Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model
by: Daan R. Löke, et al.
Published: (2021-01-01)

Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
by: Roxan F. C. P. A. Helderman, et al.
Published: (2019-01-01)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers
by: Pei-Qi Lim, et al.
Published: (2022-09-01)

Laparoscopic HIPEC: A bridge between open and closed-techniques
by: Marco Lotti, et al.
Published: (2016-01-01)

Mininvasive Cytoreduction Surgery plus HIPEC for Epithelial Ovarian Cancer: A Systematic Review
by: Carlo Ronsini, et al.
Published: (2023-02-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in an Australian institution: lessons from 20 years’ experience
by: R. Farrell, et al.
Published: (2022-09-01)

Does additional HIPEC help after CRS in peritoneal disseminated gastric cancer?
by: Rau Beate, et al.
Published: (2017-12-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

High intra-abdominal pressure during hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery (CRS) for peritoneal surface malignancies
by: Louis Choon Kit Wong, et al.
Published: (2022-12-01)

Can baseline quality of life scores predict for morbidity and survival after CRS and HIPEC: a prospective study of 151 patients
by: Chia Claramae Shulyn, et al.
Published: (2022-04-01)

HIPEC in Peritoneal Metastasis of Gastric Origin: A Systematic Review of Regimens and Techniques
by: Felix Gronau, et al.
Published: (2022-03-01)

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review
by: Sophie J. M. Reijers, et al.
Published: (2023-03-01)

Zdravljenje bolnikov s karcinozo peritoneja s HIPEC
by: Barbka Novak
Published: (2010-06-01)

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
by: Enrico Maria Pasqual, et al.
Published: (2023-01-01)

Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in small bowel adenocarcinoma with peritoneal metastasis: a systematic review
by: Chen Vicky, et al.
Published: (2022-11-01)

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey
by: Bhandoria Geetu, et al.
Published: (2021-06-01)

Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery for gastric carcinoma at high risk of peritoneal carcinomatosis: short and long-term outcomes (GOETH STUDY)—a collaborative randomized controlled trial by ACOI, FONDAZIONE AIOM, SIC, SICE, and SICO
by: A. Di Giorgio, et al.
Published: (2022-12-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review
by: Felix Che-lok Chow, et al.
Published: (2021-01-01)

Incidence of Post-operative Pulmonary Complications Following Cytoreductive Surgeries and HIPEC- A Retrospective Analytic Study
by: Roopesh Sureshan, et al.
Published: (2023-10-01)

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis
by: Alba Fernández-Candela, et al.
Published: (2021-06-01)

Anestesia en la Cirugía Citorreductora y la Quimioterapia hipertérmica intraperitoneal (HIPEC)
by: Carlos Mora Fernández, et al.
Published: (2014-06-01)

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
by: Thorsten O. Götze, et al.
Published: (2021-10-01)

Prophylactic Hyperthermic Intraperitoneal Chemotherapy for Patients at High Risk of Developing Gallbladder Cancer Peritoneal Metastases: Case Report and Rationale for a Prospective Clinical Trial
by: Alexander E. Crum, et al.
Published: (2024-01-01)

Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies
by: Megan M. Harper, et al.
Published: (2022-05-01)

Current Evidence for the Use of HIPEC and Cytoreductive Surgery in Gastric Cancer Metastatic to the Peritoneum
by: Anish J. Jain, et al.
Published: (2023-10-01)

THE ROLE OF HIPEC IN PERITONEAL CARCINOMATOSIS DUE TO COLORECTAL CANCER – PROCEDURE, COMPLICATIONS, AND LITERATURE EVIDENCE
by: Iulian Slavu, et al.
Published: (2020-12-01)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Summary of Key Clinical Trials
by: Kevin M. Turner, et al.
Published: (2022-06-01)

Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model
by: Manoğlu Berke, et al.
Published: (2023-05-01)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
by: Wei-Chun Chen, et al.
Published: (2022-10-01)

A novel method of bedside hyperthermic intraperitoneal chemotherapy as adjuvant therapy for stage-III gastric cancer
by: Lili Liu, et al.
Published: (2022-12-01)

Changes of microelement homeostasis when modeling HIPEC with cisplatine
by: E. D. Pykhtieieva, et al.
Published: (2019-02-01)

Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC
by: Taliya Lantsman, et al.
Published: (2022-02-01)

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial
by: Lili Liu, et al.
Published: (2023-12-01)

The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
by: Beatrice J. Sun, et al.
Published: (2023-10-01)